MET and cancer: In OC, CAFs stimulate cancer invasiveness and chemo-resistance through the secretion of hepatocyte growth factor (HGF), glucose-regulated protein 78 (GRP78), and the activation of hepatocyte growth factor receptor HGFR (also known as cMet)/PI3K/AKT signaling pathway [233,234].